Loopbaan van Colin Meyer
Eerdere bekende functies van Colin Meyer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 10-09-2013 | 07-02-2022 |
| Corporate Officer/Principal | 07-02-2022 | 26-09-2023 |
Opleiding van Colin Meyer
| University of Virginia | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
| SMU-Cox School of Business | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
- Beurs
- Insiders
- Colin Meyer
- Ervaring
